Skip to content
Home/Companies/Pharma Services/Aliri
Aliri

Aliri

Pharma Services·US·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Aliri?

Aliri is currently owned by ARCHIMED through MED III (2021 vintage), since 2021.

Hand-verified · updated 2026-04-21

ARCHIMED
Investor
ARCHIMED
MED III · 2021 · Buyout

Key facts

HQUnited States
SectorPharma Services
Websitealiribio.com

More from MED III

Other portfolio companies in the same fund.

BioVendor Group
Active
MedTechCzech Republic· 2025
DermaPharm
DermaPharm
Active
HealthTechDenmark· 2025
Natus Sensory
Natus Sensory
Active
MedTechUS· 2022
PlasmidFactory
PlasmidFactory
Active
BiotechGermany· 2022
Title21 Health Solutions
Title21 Health Solutions
Active
HealthTechUS· 2022
Cardioline
Cardioline
Active
MedTechItaly· 2021

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Advantice Health
Advantice Health
Active
TA AssociatesUS
Alvogen
Alvogen
Active
CVC Capital Partners
CANbridge
CANbridge
Active
General AtlanticChina
Ceva
Ceva
Exited 2025
iXO Private EquityFrance
to
curia
curia
Active
The Carlyle GroupUS
Ideal Cures Pvt. Ltd.
Ideal Cures Pvt. Ltd.
Active
TA AssociatesIndia
Track Aliri

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Aliri.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue